APN
APN
APN - Aspen Pharmacare Holdings Limited - Trading update
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")
Trading update
Aspen shareholders are hereby advised that headline earnings per
share, for the 12 months ended 30 June 2010, are expected to exceed
those reported in the comparative period, ended 30 June 2009, by 20%
to 25%. Earnings per share are anticipated to exceed those of the
comparative period by 30% to 35%. The lower increase in headline
earnings per share is caused by the exclusion of non-recurring
capital profits and losses in the determination thereof. The Group`s
South African business has been the leading contributor to the
growth recorded.
The financial results on which this trading announcement is based
have not been reviewed or reported on by Aspen`s external auditors.
Aspen`s results are scheduled to be published on SENS on 15
September 2010.
Woodmead
23 August 2010
Sponsor
Investec Bank Limited
Date: 23/08/2010 11:39:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
